Every filing for 80880W106 since 12/18/2024, newest first.
| Filer | % of Class | Filed |
|---|---|---|
| Oramed Pharmaceuticals Inc. 13G/A Amendment 1 | 9.9% |
5/8/2025
Event 3/31/2025
|
| SCLX Stock Acquisition JV LLC 13D/A Amendment 5 | 21.1% |
1/23/2025
Event 1/21/2025
|
| Oramed Pharmaceuticals Inc. 13G | 6.2% |
1/17/2025
Event 1/13/2025
|
| SCLX Stock Acquisition JV LLC 13D/A Amendment 4 | 22.8% |
1/6/2025
Event 1/2/2025
|
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q2 | 1 | 3.05 k | $1.00k |
| 2025 Q1 | 80 | 44.9 M | $11.2M |
| 2024 Q4 | 102 | 49.1 M | $20.9M |
| 2024 Q3 | 95 | 34.6 M | $32.0M |
| 2024 Q2 | 92 | 40.6 M | $78.3M |
| 2024 Q1 | 103 | 29.5 M | $47.0M |
| 2023 Q4 | 93 | 27.1 M | $55.2M |
| 2023 Q3 | 85 | 29.5 M | $41.3M |
| 2023 Q2 | 95 | 21.5 M | $120M |
| 2023 Q1 | 89 | 12.7 M | $104M |
| 2022 Q4 | 8 | 53.0 k | $240k |